Siglec-15 promotes progression of clear renal cell carcinoma

被引：4
|
作者：
Wen-Bo Yang
Cai-Peng Qin
Yi-Qing Du
Song-Chen Han
Tao Xu
机构：
[1] Beijing 100044
[2] ChinaDepartment of Urology
[3] Department of Urology
[4] Peking University People’s Hospital
来源：
中华医学杂志(英文版) | 2021年 / 134卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R737.11 [肾、肾盂肿瘤];
学科分类号：
100214 ;
摘要：
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma, accounting for approximately 80% of cases. Although most patients in the early stages of ccRCC can be cured
引用
收藏
页码：2635 / 2637
页数：3
相关论文
共 50 条
  • [1] Siglec-15 promotes progression of clear renal cell carcinoma
    Yang, Wen-Bo
    Qin, Cai-Peng
    Du, Yi-Qing
    Han, Song-Chen
    Xu, Tao
    [J]. CHINESE MEDICAL JOURNAL, 2021, 134 (21) : 2635 - 2637
  • [2] LINC00973 is involved in cancer immune suppression through positive regulation of Siglec-15 in clear-cell renal cell carcinoma
    Liu, Yanbin
    Li, Xingzhi
    Zhang, Changming
    Zhang, Hui
    Huang, Yali
    [J]. CANCER SCIENCE, 2020, 111 (10) : 3693 - 3704
  • [3] Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway
    Fan, Meng-ke
    Zhang, Guo-chuan
    Chen, Wei
    Qi, Li-li
    Xie, Ming-fang
    Zhang, Yue-yao
    Wang, Ling
    Zhang, Qi
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia
    Pillsbury, Claire E.
    Dougan, Jodi
    Rabe, Jennifer L.
    Fonseca, Jairo A.
    Zhou, Chengjing
    Evans, Alyssa N.
    Abukharma, Hasan
    Ichoku, Ona
    Gonzalez-Flamenco, Gloria
    Park, Sunita I.
    Aljudi, Ahmed
    DeRyckere, Deborah
    Castellino, Sharon M.
    Rafiq, Sarwish
    Langermann, Solomon
    Liu, Linda N.
    Henry, Curtis J.
    Porter, Christopher C.
    [J]. CANCER RESEARCH COMMUNICATIONS, 2023, 3 (07): : 1248 - 1259
  • [5] Elucidating the role and mechanisms by which siglec-15 promotes immune dysregulation in lymphoma
    Francis, Dailia B.
    Dougan, Jodi
    Pillsbury, Claire
    Park, Sunita
    Liu, Linda
    Porter, Christopher
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [6] Siglec-15: An Attractive Immunotherapy Target
    Poh, Alissa
    [J]. CANCER DISCOVERY, 2020, 10 (01) : 7 - 8
  • [7] Development of an immunohistochemical assay for Siglec-15
    Shafi, Saba
    Aung, Thazin Nwe
    Robbins, Charles
    Zugazagoitia, Jon
    Vathiotis, Ioannis
    Gavrielatou, Niki
    Yaghoobi, Vesal
    Fernandez, Aileen
    Niu, Shuqiong
    Liu, Linda N.
    Cusumano, Zachary T.
    Leelatian, Nalin
    Cole, Kimberley
    Wang, He
    Homer, Robert
    Herbst, Roy S.
    Langermann, Sol
    Rimm, David L.
    [J]. LABORATORY INVESTIGATION, 2022, 102 (07) : 771 - 778
  • [8] TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma
    Pan, Qiufeng
    Cheng, Gong
    Liu, Yuenan
    Xu, Tianbo
    Zhang, Hao
    Li, Bing
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 56 (05) : 1101 - 1114
  • [9] Leptin Is Associated with Poor Clinical Outcomes and Promotes Clear Cell Renal Cell Carcinoma Progression
    Fan, Wen-Lang
    Yeh, Yuan-Ming
    Liu, Tsung-Ta
    Lin, Wei-Ming
    Yang, Tse-Yen
    Lee, Chao-Wei
    Lin, Tsung-Chieh
    [J]. BIOMOLECULES, 2021, 11 (03) : 1 - 15
  • [10] Epigenetic regulation of FOXI2 promotes clear cell renal cell carcinoma progression
    Zhou, Shuai
    Cheng, Cong
    Liao, Yi Xiang
    Wang, Li
    Zeng, Jin Min
    Zhou, Fang Fang
    Zhang, Xiu Qin
    Yang, Tao
    [J]. HELIYON, 2024, 10 (08)
12345